---
title: "On October 28th, Healthgen Biotechnology will be listed and will be included in the Sci-Tech Innovation Growth Tier from the date of listing"
description: "On the evening of October 23rd, Healthgen Biotechnology announced that its stock will be listed on the Sci-Tech Innovation Board on October 28th. As of the announcement date, Healthgen Biotechnology h"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262457773.md"
published_at: "2025-10-23T13:52:42.000Z"
---

# On October 28th, Healthgen Biotechnology will be listed and will be included in the Sci-Tech Innovation Growth Tier from the date of listing

> On the evening of October 23rd, Healthgen Biotechnology announced that its stock will be listed on the Sci-Tech Innovation Board on October 28th. As of the announcement date, Healthgen Biotechnology has not yet turned a profit and will be included in the Sci-Tech Growth Tier from the date of listing

On the evening of October 23rd, Healthgen Biotechnology announced that its stock will be listed on the Sci-Tech Innovation Board on October 28th. As of the announcement date, Healthgen Biotechnology has not yet turned a profit and will be included in the Sci-Tech Growth Tier from the date of listing

### Related Stocks

- [688765.CN - Healthgen Biotechnology](https://longbridge.com/en/quote/688765.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 3.5 亿首付款、总额达 85 亿美元！信达生物与礼来合作布局肿瘤免疫新药研发 | 信达生物与礼来达成突破性合作，将联合开发肿瘤及免疫新药。此次交易预付款 3.5 亿美元，总额最高达 85 亿美元。双方摒弃传统授权，采用从零开始的共同研发模式，标志着中国药企创新力获全球顶尖药企深度认可，开启全球战略协作新篇章。 | [Link](https://longbridge.com/en/news/275269682.md) |
| 数十名民主党人要求将新任命的妇产科医生从疫苗咨询委员会中撤职 | 数十名民主党立法者呼吁将两名妇产科医生，亚当·乌拉托博士（Dr. Adam Urato）和金伯莉·比斯博士（Dr. Kimberly Biss），从免疫实践咨询委员会（ACIP）中移除，原因是他们持有反疫苗观点。他们在致卫生与公共服务部部长 | [Link](https://longbridge.com/en/news/275769715.md) |
| 万泰生物的董事长计划减持股份 | 万泰生物的董事长将减持股份 | [Link](https://longbridge.com/en/news/275400998.md) |
| Godavari Biorefineries 公司在 12 月季度的合并净利润为 8250 万卢比 | Godavari Biorefineries Ltd：Godavari Biorefineries Ltd 2023 年 12 月季度合并净利润 8250 万卢比；2023 年 12 月季度合并营业收入 46 亿卢比 | [Link](https://longbridge.com/en/news/275909082.md) |
| Xintela 完成了关于使用 XSTEM 治疗难愈合腿部溃疡的临床研究 | Xintela AB：完成了 XSTEM 在难愈性腿部溃疡中的临床研究，主要目标是调查安全性和耐受性，已实现 | [Link](https://longbridge.com/en/news/275910672.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.